vs

Side-by-side financial comparison of Draganfly Inc. (DPRO) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.7M, roughly 1.0× Draganfly Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -409.2%, a 258.7% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -8.7%).

Draganfly Inc. is a technology firm specializing in commercial drone design, manufacturing, and sales, plus supporting software and custom aerial data solutions. It serves public safety, agriculture, industrial inspection, disaster response, and mapping segments, with core North American markets and a global client base.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

DPRO vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.0× larger
IVF
$1.8M
$1.7M
DPRO
Growing faster (revenue YoY)
IVF
IVF
+31.3% gap
IVF
22.6%
-8.7%
DPRO
Higher net margin
IVF
IVF
258.7% more per $
IVF
-150.5%
-409.2%
DPRO

Income Statement — Q2 FY2024 vs Q3 FY2025

Metric
DPRO
DPRO
IVF
IVF
Revenue
$1.7M
$1.8M
Net Profit
$-7.1M
$-2.6M
Gross Margin
26.6%
Operating Margin
-93.1%
Net Margin
-409.2%
-150.5%
Revenue YoY
-8.7%
22.6%
Net Profit YoY
-2.6%
-62.2%
EPS (diluted)
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DPRO
DPRO
IVF
IVF
Q3 25
$1.8M
Q2 25
$1.9M
Q1 25
$1.6M
Q4 24
$1.7M
Q3 24
$1.4M
Q2 24
$1.7M
$1.8M
Q1 24
$1.6M
Q4 23
$1.4M
Net Profit
DPRO
DPRO
IVF
IVF
Q3 25
$-2.6M
Q2 25
$-5.3M
Q1 25
$-17.4M
Q4 24
$-3.6M
Q3 24
$-1.6M
Q2 24
$-7.1M
$-2.2M
Q1 24
$-1.6M
Q4 23
$-2.0M
Gross Margin
DPRO
DPRO
IVF
IVF
Q3 25
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
26.6%
53.1%
Q1 24
45.3%
Q4 23
33.0%
Operating Margin
DPRO
DPRO
IVF
IVF
Q3 25
-93.1%
Q2 25
-160.4%
Q1 25
-1042.1%
Q4 24
-202.0%
Q3 24
-90.7%
Q2 24
-100.9%
Q1 24
-95.7%
Q4 23
-109.2%
Net Margin
DPRO
DPRO
IVF
IVF
Q3 25
-150.5%
Q2 25
-283.6%
Q1 25
-1060.1%
Q4 24
-211.3%
Q3 24
-113.8%
Q2 24
-409.2%
-122.2%
Q1 24
-101.3%
Q4 23
-144.4%
EPS (diluted)
DPRO
DPRO
IVF
IVF
Q3 25
$-0.77
Q2 25
$-13.30
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55
Q4 23
$-59.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DPRO
DPRO
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$5.3M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$-2.6M
$5.8M
Total Assets
$9.9M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DPRO
DPRO
IVF
IVF
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$5.3M
Q1 24
Q4 23
Total Debt
DPRO
DPRO
IVF
IVF
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
DPRO
DPRO
IVF
IVF
Q3 25
$5.8M
Q2 25
$2.6M
Q1 25
$3.3M
Q4 24
$12.7M
Q3 24
$-23.3K
Q2 24
$-2.6M
$1.4M
Q1 24
$10.2K
Q4 23
$892.8K
Total Assets
DPRO
DPRO
IVF
IVF
Q3 25
$18.8M
Q2 25
$19.3M
Q1 25
$31.7M
Q4 24
$46.4M
Q3 24
$17.0M
Q2 24
$9.9M
$17.8M
Q1 24
$17.3M
Q4 23
$18.5M
Debt / Equity
DPRO
DPRO
IVF
IVF
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DPRO
DPRO
IVF
IVF
Operating Cash FlowLast quarter
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DPRO
DPRO
IVF
IVF
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.5M
Q4 24
$-617.4K
Q3 24
$-640.8K
Q2 24
$-1.5M
Q1 24
$-260.6K
Q4 23
$-714.9K
Free Cash Flow
DPRO
DPRO
IVF
IVF
Q3 25
$-1.8M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
Q3 24
Q2 24
$-1.5M
Q1 24
$-310.3K
Q4 23
FCF Margin
DPRO
DPRO
IVF
IVF
Q3 25
-101.6%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
Q3 24
Q2 24
-82.3%
Q1 24
-19.7%
Q4 23
Capex Intensity
DPRO
DPRO
IVF
IVF
Q3 25
0.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
Q3 24
0.0%
Q2 24
3.0%
Q1 24
3.2%
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons